聯影醫療(688271.SH):本次詢價轉讓價格為108.66元/股
格隆匯3月17日丨聯影醫療(688271.SH)公佈,經向機構投資者詢價後,初步確定的轉讓價格為108.66元/股。參與本次詢價轉讓報價的機構投資者家數為29家,涵蓋了基金管理公司、合格境外機構投資者、證券公司、保險公司、私募基金管理人、期貨公司等專業機構投資者。參與本次詢價轉讓報價的機構投資者合計有效認購股份數量為65,680,000股,對應的有效認購倍數為2.26倍。本次詢價轉讓擬轉讓股份已獲全額認購,初步確定受讓方為25家機構投資者,擬受讓股份總數為29,086,400股。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.